DKDmitri Koroliouk

Dmitri Koroliouk

*This is an algorithmically generated author record based on publicly available information.

Dmitri Koroliouk has a total of 64 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Five Conserved microRNAs Dominate the Small-RNA Pool of Three Arid-Zone Camel-Forage Plants: De Novo Repertoires and a Species-Matched Test of Cross-Kingdom Targeting in the Dromedary

    by Maksym Zoziuk, Abdirahman Ali, Abel Dafogo Djibagao, Carla Montesano, Marina Potestà, Alessandra Minchella, Alessandro Terrinoni, Maria Cristina Caroleo, Giulia Cappelli, Dimitri Koroliouk, et al.

    Background: Camel husbandry underpins food security in drylands, and dromedary (Camelus dromedarius) milk is valued as a functional food whose composition is thought to be shaped by the desert forage that camels browse. Dietary plant microRNAs (miRNAs) have been proposed as one molecular route linking diet to mammalian physiology, and two interactions are widely cited from experimental reports: rice miR168a repressing LDLRAP1 and plant miR159 repressing TCF7. The hypothesis remains contested, however, and it has not been tested for camel forage against camel transcripts. Methods: We generated de novo, hairpin-based miRNA repertoires for three arid-zone forage plants relevant to camel feeding (Moringa oleifera, Ziziphus jujuba, Medicago sativa) and screened the mature miRNAs against 48,746 reconstructed C. dromedarius 3′-UTRs under stringent thresholds, retaining one transcript per gene, weighting interactions by read abundance, normalising scores for 3′-UTR length, and testing over-representation against a matched background. The two previously reported cross-kingdom pairs served as internal positive controls and seed-level grouping as a sensitivity control. Results: The three forages yielded 170 hairpin-validated miRNA loci (81 M. sativa, 49 Z. jujuba, 40 M. oleifera) peaking at 21 nt, collapsing to 116 mature sequences and 104 seed groups. The pooled read set was strongly concentrated: five mature sequences shared by all three species carried 51% of reads, miR159 alone 31%, and 19 sequences assignable to conserved miRBase families carried 64%. The pipeline recovered the reported miR168a–LDLRAP1 pairing in the camel; the miR159–TCF7 pairing, by contrast, was not recovered, although TCF7 was among the genes targeted by other plant miRNAs. Genome-wide, predicted targeting was sparse (median 2 miRNAs per gene) and no GO, KEGG or Hallmark category was enriched at either threshold (best FDR 0.56); the nominal p-value distribution was approximately uniform, giving no evidence of systematic enrichment under the tested framework. Targeting multiplicity scaled with 3′-UTR length (Pearson r = 0.63; Spearman ρ = 0.58), so apparent “hub” genes are largely long-3′-UTR genes. Of 19, 12 curated milk-fat and lactation genes were among predicted targets, without over-representation (Fisher p = 0.36). Conclusions: A sensitive, species-matched analysis recovered a previously reported cross-kingdom pairing yet found no coordinated enrichment of dietary plant miRNAs on the dromedary transcriptome, and showed that an individual cross-kingdom pairing cannot be assumed to transfer between mammalian species. The work provides a first forage miRNA resource in the context of camel nutrition, sets out a reusable, species-matched analytical framework for cross-kingdom claims, and narrows future experimental work to five abundant forage-derived sequences and a short list of candidate genes (LDLRAP1, TCF7/TCF7L2, PRLR, INSR).

  • Open Access

    Conserved Core and Species-Specific Signatures in the Milk Exosomal microRNA Targetome: A Preliminary Comparative In Silico Analysis of Human, Cow, Goat and Donkey Milk

    by Maksym Zoziuk, Abel Dafogo Djibagaou, Alessandro Terrinoni, Dimitri Koroliouk, Vittorio Colizzi

    Milk-derived extracellular vesicles (EVs) transport microRNAs (miRNAs) that are unusually stable and have been proposed to survive digestion and modulate gene expression in the consumer, although their dietary bioavailability and physiological relevance remain debated. How the predicted regulatory potential of these miRNAs differs among the milks of different animals most relevant to human nutrition has not been systematically compared. Here, we performed an integrative in silico analysis of publicly available small-RNA sequencing data from 29 milk and milk-cell samples of human, cow, goat, and donkey origin. miRNAs were quantified against human (hsa) miRBase references—thereby restricting the analysis to evolutionarily conserved miRNAs with human orthologs—and their predicted effect on the human transcriptome was modeled by integrating predicted (mirDIP database) and experimentally supported (TarBase v9 database) miRNA–target interactions into a per-gene, per-species weighted targeting score. Because miRNAs act predominantly as repressors, this score is read as a prediction of which genes would be post-transcriptionally down-regulated in a recipient. miR-148a-3p dominated the exosomal spectrum of all four species (human, cow, goat, and donkey; ≈21.5% of pooled abundance), and the twenty most abundant miRNAs accounted for roughly three quarters of the signal. Of 4577 robustly targeted genes, a 1809-gene conserved “pan-milk” core showed the highest cross-species targeting and was enriched for transcriptional regulation, PI3K–Akt, MAPK, and TGF-β/SMAD signaling, autophagy and—strikingly—the components of the RNA-interference machinery itself. Species-restricted gene sets recapitulated biologically plausible programs, including a human-biased neuronal/axon-guidance and chromatin module, a donkey-biased transcriptional, epithelial, and immune (CD47) module, and a ruminant lipid/cholesterol and insulin–mTOR module. Across categories, we observed a reproducible confidence–exclusivity trade-off. We emphasize that these results are computational predictions that assume dietary miRNA uptake and do not constitute experimental validation. We provide the complete targetome as a hypothesis-generating resource to prioritize candidate genes, pathways, and milk types for future functional, nutritional, and epigenetic investigation. Across the 29 samples from the four species, miRNA composition segregated by species (silhouette width = 0.82, a cluster-separation measure ranging from −1 to 1, with values near 1 indicating well-separated groups) and the category structure exceeded a permutation null, indicating that the between-species signal is robust to differences in dataset origin and milk state.


  • Open Access

    Conserved Core and Species‐Specific Signatures in the Milk Exosomal microRNA Targetome: A Comparative In Silico Analysis of Human, Cow, Goat and Donkey Milk

    by Maksym Zoziuk, Abel Dafogo Djibagaou, Alessandro Terrinoni, Dimitri Koroliouk, Vittorio Colizzi

    Milk-derived extracellular vesicles (EVs) transport microRNAs (miRNAs) that are un-usually stable and have been proposed to survive digestion and modulate gene expres-sion in the consumer, although their dietary bioavailability and physiological rele-vance remain debated. How the predicted regulatory potential of these miRNAs differs among the milks most relevant to human nutrition has not been systematically com-pared. Here we performed an integrative in silico analysis of publicly available small-RNA sequencing data from 29 milk and milk-cell samples of human, cow, goat and donkey origin. miRNAs were quantified against human (hsa) miRBase refer-ences—thereby restricting the analysis to evolutionarily conserved miRNAs with hu-man orthologs—and their predicted effect on the human transcriptome was modeled by integrating predicted (mirDIP) and experimentally supported (TarBase v9) miR-NA–target interactions into a per-gene, per-species weighted targeting score. Because miRNAs act predominantly as repressors, this score is read as a prediction of which genes would be post-transcriptionally down-regulated in a recipient. miR-148a-3p dominated the exosomal spectrum of all four species (≈21.5% of pooled abundance), and the twenty most abundant miRNAs accounted for roughly three quarters of the signal. Of 4,577 robustly targeted genes, a 1,809-gene conserved “pan-milk” core showed the highest cross-species targeting and was enriched for transcriptional regu-lation, PI3K–Akt, MAPK and TGF-β/SMAD signaling, autophagy and—strikingly—the components of the RNA-interference machinery itself. Species-restricted gene sets re-capitulated biologically plausible programs, including a human-biased neu-ronal/axon-guidance and chromatin module, a donkey-biased transcriptional, epithe-lial and immune (CD47) module, and a ruminant lipid/cholesterol and insulin–mTOR module. Across categories we observed a reproducible confidence–exclusivity trade-off. We emphasize that these results are computational predictions that assume dietary miRNA uptake and do not constitute experimental validation. We provide the complete targetome (Supplementary Materials S1–S9) as a hypothesis-generating re-source to prioritize candidate genes, pathways and milk types for future functional, nutritional and epigenetic investigation.


  • Open Access

    Weighted Epigenetic Profiling of Milk miRNAs Across Human, Bovine, and Camel Species: A Comparative Global Score

    by Maksym Zoziuk, Abel Dafogo Djibagaou, Koutaya Dezoumbe, Noubaramadji Yamti Suitombaye, Amine Akouya, Abdirahman Ali, Giulia Cappelli, Dimitri Koroliouk, Maurizio Mattei, Maria Cristina Caroleo, et al.

    Milk microRNAs (miRNAs) are key mediators of maternal–offspring communication, potentially influencing postnatal development through systemic epigenetic regulation. While miRNAs in human and bovine milk are extensively studied, the regulatory landscape of camel milk remains underexplored despite its unique therapeutic reputation. In this study, we conducted a comparative cross-species analysis of miRNA targets from human (Homo sapiens), bovine (Bos taurus), and camel (Camelus dromedarius) milk. To estimate regulatory impact, we implemented the Global Score, a weighted metric integrating quantitative miRNA abundance with thermodynamic binding affinity (miRWalk 2.0), cross-validated by multi-algorithm statistical consensus via mirDIP 5.2.Analysis revealed distinct species-specific miRNA concentration strategies: human milk maintains a highly diversified "regulatory symphony" (90% mass distributed across 35 miRNAs), while camel milk utilizes a "biological intervention" strategy, with only 12 miRNAs constituting 90% of the pool and miR-148a exerting extreme dominance (61.8%). A conserved regulatory core (Common All) was identified, accounting for over 80% of the total regulatory weight, primarily associated with neuroplasticity and MAPK/Ras signaling.Camel milk miRNAs displayed a distinctive therapeutic signature, uniquely targeting pivotal immune and metabolic nodes, specifically STAT3 (linked to Th17 cell differentiation) and PPARD, providing a molecular basis for its reported anti-inflammatory and anti-diabetic effects. Conversely, human milk showed high-confidence human-specific targeting of NLGN3, essential for synaptic organization. Bovine milk exhibited a significantly closer functional alignment to the human "epigenetic template" (14.8% shared genes) than camel milk (1.5%), particularly in pathways maintaining genomic stability (e.g., XPO1). These findings demonstrate that milk miRNAs operate through both a universal developmental backbone and specialized regulatory environments, offering a comparative framework for applications in clinical nutrition and precision medicine.

  • Open Access

    Human miRNAs in Cancer: Statistical Trends and Cross Kingdom Approach

    by Maksym Zoziuk, Vittorio Colizzi, Maurizio Mattei, Pavlo Krysenko, Roberta Bernandini, Fabio Massimo Zanzotto, Stefano Marini, Dmitri Koroliouk

    MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression post-transcriptionally and are frequently dysregulated in cancer. While most studies focus on individual miRNAs, global patterns and their potential cross-kingdom similarities remain underexplored. This study aims to identify statistically stable human miRNAs in cancer, their key target genes, and analyze sequence complementarity with plant miRNAs to highlight patterns for future research. Experimentally validated human miRNA–gene interactions from miRTarBase were integrated with TCGA expression data across multiple cancers. Using a nonlinear threshold (critical threshold III), 115 underexpressed and 93 overexpressed miRNAs were identified as regulators of 200 genes with the strongest dysregulation. Further, 10,898 plant miRNAs from 127 species were computationally compared to these human miRNAs, and average complementarity scores were calculated to identify plant miRNAs most similar to under- or overexpressed human miRNAs. Statistical parameters such as membership ratios and experiment counts quantified miRNA expression stability. Subsets of human miRNAs exhibited consistent over- or underexpression across cancers, with concordant target gene expression patterns. Several plant miRNAs showed higher complementarity to underexpressed human miRNAs, suggesting reproducible cross-kingdom sequence similarity patterns. Differences in complementarity were modest but systematic, providing a computational framework for prioritizing candidate miRNAs for further study. This work establishes a computational approach integrating human miRNA–gene interactions, cancer expression data, and plant miRNA sequences. It identifies statistically stable miRNAs, key target genes, and cross-kingdom sequence similarities without implying functional or therapeutic activity. The framework can guide future experimental studies in miRNA regulation, comparative genomics, and molecular evolution.


  • Health Sustainability: Perpetual Genetic Response the Environmental Chemical Composition

    by Maksym Zoziuk, Dimitri Koroliouk, Maurizio Mattei, Roberta Bernardini, Fabio Massimo Zanzotto, Pavlo Krysenko, Stefano Marini, Vittorio Colizzi

  • Open Access

    Computational identification of plant microRNAs targeting Plasmodium falciparum: a new strategy to address the challenges of modern malaria treatment

    by Maksym Zoziuk, Dmitri Koroliouk, Andrillene Laure Deutou Wondeu, Wilfred Mbacham, Giacomo Maria Paganotti, Noubaramadji Yamti Suitombaye, Amine Akouya, Maurizio Mattei, Marta Giovanetti, Vittorio Colizzi

    Malaria remains one of the greatest challenges to global health, with Plasmodium falciparum responsible for the majority of severe cases and deaths, despite significant progress in diagnosis and treatment. Resistance to antimalarial drugs, particularly associated with P. falciparum kelch13 (PfK13) mutations in Africa, as well as resistance to partner drugs such as piperaquine and lumefantrine, and limited efficacy of vaccines, necessitate the search for new therapeutic approaches. This review analyzes the current challenges in malaria treatment, focusing on the role of microRNAs (miRNAs) as potential regulators of the immune response and potential therapeutic targets. Special attention is paid to the computational screening of plant miRNAs that have promise in suppressing the expression of parasitic genes in P. falciparum. We reviewed recent literature on the molecular mechanisms of antimalarial drug resistance and the potential applications of miRNAs in malaria therapy, focusing on host- and parasite-derived miRNAs, their roles in pathogenesis, and experimental therapeutic strategies, including nanoparticle-mediated miRNA delivery. Emerging data indicate that specific host miRNAs (e.g., miR-451, miR-223) can modulate erythrocytic invasion, inflammatory responses, and disease outcomes. In parallel, advances in RNA-based therapeutics demonstrate the feasibility of miRNA mimics and inhibitors as adjunctive tools to complement existing antimalarial regimens. The integration of miRNA-based approaches into malaria therapy represents a promising frontier that could overcome the limitations of conventional drug-based strategies. Future research should prioritize the functional characterization of miRNAs, optimization of delivery systems, and evaluation of combinatorial therapies to enhance clinical translation.

  • Open Access

    Computational identification of plant microRNAs targeting Plasmodium falciparum: a new strategy to address the challenges of modern malaria treatment

    by Maksym Zoziuk, Dmitri Koroliouk, Andrillene Laure Deutou Wondeu, Wilfred Mbacham, Giacomo Maria Paganotti, Noubaramadji Yamti Suitombaye, Amine Akouya, Maurizio Mattei, Marta Giovanetti, Vittorio Colizzi

    Malaria remains one of the greatest challenges to global health, with Plasmodium falciparum responsible for the majority of severe cases and deaths, despite significant progress in diagnosis and treatment. Resistance to antimalarial drugs, particularly associated with P. falciparum kelch13 (PfK13) mutations in Africa, as well as resistance to partner drugs such as piperaquine and lumefantrine, and limited efficacy of vaccines, necessitate the search for new therapeutic approaches. This review analyzes the current challenges in malaria treatment, focusing on the role of microRNAs (miRNAs) as potential regulators of the immune response and potential therapeutic targets. Special attention is paid to the computational screening of plant miRNAs that have promise in suppressing the expression of parasitic genes in P. falciparum. We reviewed recent literature on the molecular mechanisms of antimalarial drug resistance and the potential applications of miRNAs in malaria therapy, focusing on host- and parasite-derived miRNAs, their roles in pathogenesis, and experimental therapeutic strategies, including nanoparticle-mediated miRNA delivery. Emerging data indicate that specific host miRNAs (e.g., miR-451, miR-223) can modulate erythrocytic invasion, inflammatory responses, and disease outcomes. In parallel, advances in RNA-based therapeutics demonstrate the feasibility of miRNA mimics and inhibitors as adjunctive tools to complement existing antimalarial regimens. The integration of miRNA-based approaches into malaria therapy represents a promising frontier that could overcome the limitations of conventional drug-based strategies. Future research should prioritize the functional characterization of miRNAs, optimization of delivery systems, and evaluation of combinatorial therapies to enhance clinical translation.


  • Open Access

    Human miRNA Expression and Plant miRNA: A Statistical Approach for Cancer Therapy

    by Maksym Zoziuk, Vittorio Colizzi, Maurizio Mattei, Pavlo Krysenko, Roberta Bernardini, Fabio Massimo Zanzotto, Stefano Marini, Dmitri Koroliouk

    Background/Objectives: The regulatory role of miRNAs in cancer is well recognized, but most studies are confined to specific cancer types or individual miRNAs. This study aims to identify miRNAs involved in global oncological mechanisms that transcend individual cancer types. Methods: We analyzed expression data from all known human miRNAs across all cancer types. A statistical approach was developed and expression distributions to define miRNAs with under- or over-expression patterns. We then studied miRNA-target gene relationships and investigated complementarity between human and plant miRNAs to propose potential therapeutic plant miRNA panels. Results: Critical miRNAs were identified based on their expression trends and impact on target genes. Plant miRNAs with strong complementarity to underexpressed human miRNAs and weak complementarity to overexpressed miRNAs were selected as candidates for therapeutic panels. Distribution patterns and key correlations were visualized using figures. Conclusions: The results suggest that an approach for making panels of selected plant miRNAs may offer therapeutic benefits by compensating for deficiencies in human miRNA expression associated with cancer. This work provides a framework for future experimental validation and therapy design.

  • Open Access

    Plant miRNAs for Improved Gene Regulation in a Wide Range of Human Cancers

    by Maksym Zoziuk, Vittorio Colizzi, Pavlo Krysenko, Maurizio Mattei, Roberta Bernardini, Fabio Massimo Zanzotto, Stefano Marini, Dmitri Koroliouk

    Determining the relationships between miRNA expression, target genes, and cancer development is critical to cancer research. The possibility of correlating miRNA expression with plant or artificial ones provides prerequisites for cancer treatment. Based on the broad database of human miRNA expression for all cancer types, we grade human miRNAs by their expression level. The identified deficient miRNAs are compared with their target genes for coincidences in their expression directions. The replacement of human miRNAs is proposed to be implemented, using plant miRNAs closest to the human-deficient ones. Such plant substitutes are identified by analyzing the average complementarity of all human under-expressed miRNAs. It was established that the number of downregulated miRNAs is almost 2.5 times greater than that of upregulated miRNAs. There is no significant correlation between the expression of miRNA and genes, implying many other expression regulation mechanisms exist. Working on the organization of experimental verification of the obtained statistical studies, we present significant regularities that provide grounds for considering some plant microRNAs as possible means of compensating for insufficient expression of regulatory microRNAs in humans and animals in a wide range of oncological diseases.